Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov:131:96-101.
doi: 10.1016/j.critrevonc.2018.09.004. Epub 2018 Sep 12.

Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies

Ming Yuan He  1 , Chloé Rancoule  2 , Amel Rehailia-Blanchard  3 , Sophie Espenel  2 , Jane-Chloé Trone  3 , Emilie Bernichon  4 , Elodie Guillaume  3 , Alexis Vallard  3 , Nicolas Magné  5
Affiliations
Review

Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies

Ming Yuan He et al. Crit Rev Oncol Hematol. 2018 Nov.

Abstract

Triple-negative breast cancer (TNBC) (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is viewed as an aggressive subgroup of breast cancer. Treating patients with TNBC remains clinically challenging. It's now well established than radiation therapy is able to improve locoregional control in breast cancer patients both after breast conserving surgery or mastectomy, with positive impact in high-risk patients for long-term survival. Biologic characterization of breast tumor different subtypes, in particular the heterogeneous subtype of TNBC could permit to adapt the treatment plan. In the present review, summarizing the molecular types, we describe clinical features and postoperative radiotherapy current situation for TNBC, and we provide new strategies and directions through an adapted radiation therapy.

Keywords: Molecular subtypes; Radiation therapy; Radiosensitization; Triple negative breast cancer.

PubMed Disclaimer